SCHEMBL9218472

SCHEMBL9218472

Oc1cccc2c1CN[C]C2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL2L1 Q07817 1/20 0.42
BAD Q92934 1/20 0.42
DRD2 P14416 2/20 0.36
DRD3 P35462 2/20 0.36
DRD1 P21728 1/20 0.34
DRD5 P21918 1/20 0.34
CHRM3 P20309 2/20 0.33
ACHE P22303 1/20 0.33
MEN1 O00255 1/20 0.33
USP2 O75604 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HPN P05981 1/20 0.33
CYP3A4 P08684 1/20 0.33
ALOX5 P09917 1/20 0.33
MAPT P10636 1/20 0.33
THRB P10828 1/20 0.33
ALOX15 P16050 1/20 0.33
TSHR P16473 1/20 0.33
PTGS1 P23219 1/20 0.33
PDE4A P27815 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29945525 0.71 BCL2L1 (0.48) BCL2L1BADDRD2DRD3DRD1
SCHEMBL19028377 0.71 BCL2L1 (0.48) BCL2L1BADDRD2DRD3DRD1
SCHEMBL3961093 0.71 BCL2L1 (0.48) BCL2L1BADDRD2DRD3DRD1
SCHEMBL37705 0.70 PNMT (0.39) ALOX15HSD17B10PNMT
Bromide SCHEMBL384160 0.69 BCL2L1 (0.47) BCL2L1BADDRD2DRD3DRD1
Hydrochloric Acid SCHEMBL11569899 0.69 BCL2L1 (0.47) BCL2L1BADDRD2DRD3DRD1
SCHEMBL9218467 0.67 BCL2L1 (0.44) BCL2L1BADDRD2DRD3DRD1
SCHEMBL3157785 0.67 PNMT (0.67) BCL2L1BADPNMT
SCHEMBL29914246 0.67 PNMT (0.67) BCL2L1BADPNMT
Hydrochloric Acid SCHEMBL15056499 0.65 PNMT (0.65) BCL2L1BADPNMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0517345-B1 Intermediates of the mureidomycin group, their preparation, and their use SANKYO CO (JP) 1995-07-19 EP claimed
EP-0317292-B1 NEW ANTIBIOTICS OF THE MUREIDOMYCIN GROUP, THEIR PREPARATION, AND THEIR THERAPEUTIC USE Sankyo Company Limited (JP) 1993-04-07 EP claimed
EP-0517345-A1 Intermediates of the mureidomycin group, their preparation, and their use SANKYO COMPANY LIMITED (JP) 1992-12-09 EP claimed
US-5041423-A Antibiotics of the mureidomycin group, their preparation, and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1991-08-20 US claimed
EP-0317292-A2 New antibiotics of the mureidomycin group, their preparation, and their therapeutic use Sankyo Company Limited (JP) 1989-05-24 EP claimed
JP-1230568-A None JP disclosed
EP-0517345-B1 Intermediates of the mureidomycin group, their preparation, and their use SANKYO CO (JP) 1995-07-19 EP disclosed
EP-0317292-B1 NEW ANTIBIOTICS OF THE MUREIDOMYCIN GROUP, THEIR PREPARATION, AND THEIR THERAPEUTIC USE Sankyo Company Limited (JP) 1993-04-07 EP disclosed
EP-0517345-A1 Intermediates of the mureidomycin group, their preparation, and their use SANKYO COMPANY LIMITED (JP) 1992-12-09 EP disclosed
US-5041423-A Antibiotics of the mureidomycin group, their preparation, and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1991-08-20 US disclosed
US-5041423-A Antibiotics of the mureidomycin group, their preparation, and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1991-08-20 US disclosed
JP-H01230568-A MUREIDOMYCIN DERIVATIVE SANKYO CO LTD 1989-09-14 JP disclosed
EP-0317292-A2 New antibiotics of the mureidomycin group, their preparation, and their therapeutic use Sankyo Company Limited (JP) 1989-05-24 EP disclosed
EP-0317292-A2 New antibiotics of the mureidomycin group, their preparation, and their therapeutic use Sankyo Company Limited (JP) 1989-05-24 EP disclosed